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Background: Cassia sieberiana is a savannah tree with a wide phytotherapeutic application including the use of its
roots in the management of various stomach disorders including gastric ulcer, stomach pains and indigestion. The
aim of the study is to evaluate the antioxidant, gastric cytoprotective prostaglandins, secretory phospholipase A2,
phytochemical and acute toxicity properties of Cassia sieberiana roots bark extract in a bid to justify its
phytotherapeutic applications in gastric ulcer.
Methods: Antioxidant and radical scavenging activities of the roots bark extract of Cassia sieberiana were assayed.
Serum secretory phospholipase A2 (sPLA2) concentration and activity and the formation of gastric mucosal
prostaglandins E2 (PGE2) and I2 (PGI2) were also assessed. Comparisons between means were performed using
analysis of variance (ANOVA) followed by Students Standard Newman-Keuls post hoc analysis to determine statistical
significance. P< 0.05 was considered significant.
Results: The extract was found to possess significant ferric reducing antioxidant power and can scavenge hydroxyl
radicals. The extract also possesses DPPH scavenging activity, can chelate ferrous ion and a dose-dependent
protective effect against lipid peroxidation and free radical generation. Prostaglandin studies showed that the roots
bark extract dose dependently increased gastric mucosal PGE2 and PGI2 levels and also decreased serum sPLA2
activity. Phytochemical analyses suggest that the roots extract contains polyhydroxyl/phenolic substances. Acute
toxicity test showed no sign of toxicity up to a dose level of 2000 mg/kg body weight p.o.
Conclusions: C. sieberiana roots extract possesses significant antioxidant and gastric cytoprotective prostaglandin
properties as well as serum secretory phospholipase A2 inhibitory activity which could be due to its content of
polyhydroxy and/or phenolic substances. This may justify its use as an anti-ulcerogenic agent in traditional medicine
in West Africa.Background
Cassia sieberiana is a savannah tree with a wide appli-
cation including the ethnopharmacological use of its
roots in the management of various stomach disorders
including gastric ulcer, stomach pains and indigestion
[1]. At the Centre for Scientific Research into Plant
Medicine (CSRPM) in Ghana, an aqueous suspension
of the powdered roots bark is used to manage abdom-
inal colic and pains associated with the joints. Earlier* Correspondence: etnartey@chs.edu.gh
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reproduction in any medium, provided the orstudies we conducted indicated that the aqueous roots
bark extract of C. sieberiana possesses anti-ulcerogenic
properties against gastric ulcers induced by various
methods [2].
Among the various factors implicated in the pathophysi-
ology of gastric ulcer disease are the roles played by en-
dogenous generation of prostaglandins (PGs) and free
radicals [3]. Free radicals play fundamental roles in many
physiological reactions. Due to their high reactivity, they
have been implicated in the causation of some degenera-
tive diseases including stress, NSAID and H. pylori
induced gastric ulcers [4,5]. They have been shown to me-
diate the micro-vascular disturbance that precedes stress,
NSAID or ischaemic reperfusion induced gastric mucosalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ulcers [5,6]. In addition studies have shown that certain
anti-oxidants also prevent gastric ulcers [7-9].
PGs, a family of lipid compounds derived from arachi-
donic acid pathway mediate a wide range of physiological
functions including modulation of inflammation and gastro-
intestinal mucosal defence. Superficial injury to the gastric
mucosa is known to trigger an acute inflammatory re-
sponse, characterized by the increase in blood flow, as well
as by plasma exudation and recruitment into the mucosa of
leukocytes [10]. While the acute inflammatory response is
aimed at reducing mucosal injury, there are circumstances
in which this response can be dysregulated and can contrib-
ute to mucosal injury [11]. The major prostaglandins pro-
duced by human and rodent gastric mucosa are PGE2 and
PGI2 and these PGs accelerate ulcer healing in both experi-
mental animal models and in humans [12,13]. The dual
contribution of PGs to inflammation and mucosal defence
present a challenge to the development of anti-inflamma-
tory drugs.
Phospholipids also play an important role in the preserva-
tion of gastrointestinal homeostasis [14]. Phospholipase A2
(PLA2), an enzyme is capable of hydrolyzing membrane
phospholipids, which in the presence of high gastric acidity
leads to mucosal damage. PLA2 mediated hydrolysis of
membrane lipids results in membrane perturbation, cell de-
granulation and stripping of cell surface receptors resulting
in gastric ulcer. High concentrations of PLA2 have been
reported in gastric mucosa [15] and PLA2 inhibitors are
known to modulate proton conductance across cell mem-
branes [16] and thus can offer gastric mucus protection
from enzymatic breakdown. As a result of our earlier study
on the phytotherapeutic ability of the roots bark of C. sie-
beriana as an anti-ulcerogenic agent, this study was con-
ducted to assess the anti-oxidative (in vitro) and gastric
mucosal prostaglandin properties of the roots bark extract
of the plant.
Methods
Preparation of roots bark extract
Fresh roots of C. sieberiana (Cassia kotschyana Oliv.) were
obtained from the grounds of the University of Ghana. The
plant was identified and authenticated at the Ghana Herbar-
ium, University of Ghana, Ghana. The chopped fresh roots
bark (750 g) were grounded and mixed with 1 L of water
and left to stand overnight. The resulting concoction was
evaporated under reduced pressure at 30°C and the concen-
trate freeze-dried to yield solid material. The freeze-dried
roots bark extract was stored at 4°C and used within 4 weeks
of production.
Animals
Male guinea pigs weighing 318 ± 30.3 g (mean ± S.D)
were used for the prostaglandin studies. They were feedmainly on the leaves of Panicum maximum (Elephant
grass) supplemented with standard laboratory diet
(GAFCO, Tema, Ghana). Fisher 344 (F344) rats weighing
230.3 ± 14.5 g (mean ± S.D) of both sexes were used for
the acute oral toxicity studies. They were also raised on
standard laboratory diet (GAFCO, Tema, Ghana). The
animal experimentation described in this study was
approved by the Ethical and Protocol Review Committee
of Noguchi Memorial Institute for Medical Research of
the University of Ghana and was conducted in accord-
ance with internationally accepted principles for labora-
tory animal use and care.
Chemicals and reagents
L-ascorbic acid (LAA) was obtained from Sigma Chem-
ical Company, St. Loius, U.S.A. All of the reagents for
the antioxidant studies were obtained from Fluka Che-
mie, Switzerland. The enzyme immunoassay kits for
prostaglandin E2 (Cat # 514010) and prostaglandin I2
(assayed as 6-keto PGF1α, Cat # 515211) as well as
secretory phospholipase A2 (human Type IIa, Cat #
585000) and secretory phospholipase A2 activity (Type
IIa, Cat # 765001) were obtained from Cayman Chemical
Company (Am Arbor, U.S.A.). Arachidonic acid, reduced
glutathione (GSH) and bovine serum albumin (BSA)
were obtained from Sigma Chemical Company (St.
Louis, MO, U.S.A.).
In vitro antioxidant studies
All of the reagents for the antioxidant studies were pre-
pared in deionised water to eliminate the contamination
of metal ions. Total phenolic concentrations were deter-
mined as described by AOAC [17]. Total reducing power
of the plant extract was determined by the method of
Yildirim et al. [18]. DPPH radical scavenging activity was
determined by the method of Zhu et al. [19]. Antioxidant
activity in a haemoglobin-induced linoleic acid system of
the roots extract was determined by a modified photom-
etry method as described by Kuo et al. [20]. The hy-
droxyl scavenging activity was measured by studying the
competition between deoxyribose and the extract for hy-
droxyl radicals generated from the Fe3+/ ascorbate/
EDTA/ H2O2 system [21]. Ferrous ion chelating effect
was determined according to the method of Dinis et al.
[22]. These assays were done in triplicate and L-ascorbic
acid (LAA) was used as positive control.
Gastric prostaglandins studies
Administration of plant extract
Different concentrations of the roots extract 250 mg/kg,
500 mg/kg and 750 mg/kg body weight, suspended in
water (as vehicle) in a total volume of 2.0 mL were admi-
nistered orally to three groups of guinea pigs made up of
5 animals per group. Treatment was repeated every
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received the vehicle instead of the roots extract.
Blood sampling
A day after the administration of the last dose of the
plant extract, each animal was anaesthetised using so-
dium pentobarbitone (60 mg/kg body weight, i.p). A total
volume of 5 mL of blood was obtained from each anaes-
thetised animal by cardiac puncture and a sample of
100 μL is diluted 1 in 9 using pre-chilled 25 mM Tris–
HCl. This portion was used for the determination of
serum secretory phospolipase A2 (sPLA2) concentration.
A different portion of the obtained blood was allowed to
clot and the serum used to estimate sPLA2 activity and
protein content. The protein content in serum was deter-
mined by the Folin-Lowry method [23].
Eicosanoid biosynthesis and assay
Briefly after euthanizing the animals, the stomach were
rinsed in pre-chilled 0.15 M KCl and then homogenised
using 0.25 M sucrose-10 mM Tris–HCl (pH 7.5). The hom-
ogenate was centrifuged at 10,000 g for 20 min at 4°C and
the supernatant centrifuged again at 105,000 g for 60 min
at 4°C. The pellet was homogenised in 0.1 M K2PO4 buffer
(pH 7.6). The eicosanoids prostaglandin E2 (PGE2) and
prostaglandin I2 (PGI2) (assayed as 6-keto PGF1α) were bio-
synthesised using GSH as co-factor in the cyclooxygenase
reaction. Reactions were terminated after 5 minutes using
100 μL of 1.0 M citric acid and assayed with ELISA kit from
Cayman Chemical Company (Am Arbor, U.S.A.).
Secretory phospholipase A2 concentration and activity
Secretory phospholipase A2 concentration and secretory
phospholipase A2 activity in the serum were assayed
using kits (Cat # 585000 and Cat # 765001 respectively)
from Cayman Chemical Company (Am Arbor, U.S.A.).
Phytochemical analyses
Standard phyto-chemical tests were used for the detection
of tannins, saponins, flavonoids and anthraquinones in the
extract [24]. Thin layer chromatography was also con-
ducted on the plant extract using different mobile phase
systems and silica gel 60F254 as the stationary phase. The
chromatograms developed were viewed under daylight,
UV light and vaporised iodine. The resolved components
under UV light were treated with 0.1 mM FeCl3.
Acute toxicity
Acute oral toxicity study was performed as per OECD-
423 guidelines (acute oral toxicity-acute toxic class
method). Specific pathogen free F344 rats of either sex
selected by random sampling technique were fasted
overnight with water ad libitum after which the extracts
(dissolved in water) were administered orally by gastricinstillation beginning from a dose of 5 mg/kg body
weight. The rats were observed for death within 48 hours
after extract administration and surviving animals
observed for 14 days for weight changes, lethargy and
behavioural modifications. If mortality was not observed,
the procedure was repeated with higher doses such as
50, 300 and 600 up to 2000 mg/kg body weight.
Statistical analysis
Comparisons between means were performed using ana-
lysis of variance (ANOVA) followed by Students Standard
Newman-Keuls post hoc analysis to determine statistical
significance. P< 0.05 was considered significant.
Results
Antioxidant studies
Amount of total phenolic compounds
Analyses of an amount of 200 μg of freeze-dried extract
of C. sieberiana yielded 75.32 ± 0.52 of gallic acid
equivalents of polyphenols. Therefore total phenolic
compounds constituted 37.66 ± 0.27% of C. sieberiana
roots bark extract.
Reducing power
The reducing power of the roots extract of C. sieberiana
and LAA as reference compound are shown in Figure 1.
The graph shows that the reducing power increased with
increasing concentration of C. sieberiana or LAA up to a
concentration of 0.8 mg/mL after which there was no fur-
ther increase in reducing power with increasing concentra-
tion of C. sieberiana extract or LAA. Analysis of the data
indicated that below a concentration of 0.6 mg/mL for both
C. sieberiana and LAA, significantly higher concentration
of C. sieberiana than LAA was required to produce the
same absorbance. The concentrations to attain one absorb-
ance unit at 700 nm were 0.28±0.03 mg/mL for C. sieberi-
ana and 0.26±0.02 mg/mL for LAA.
DPPH radical scavenging activity
In the current study the scavenging activities of DPPH
exerted by C. sieberiana and LAA shows a linear response
curve (Figure 2) and the IC50 estimated for C. sieberiana
and LAA were 0.095±0.006 mg/mL and 0.06±0.004 mg/
mL respectively. This significantly different IC50 value of the
crude extract was however 63.2% that of LAA.
Scavenging effect on hydroxyl radical
In this study, the roots extract was able to achieve a 62%
maximum scavenging activity when its concentration was
more than 10 mg/mL (Figure 3). Nevertheless, LAA had
about 70% scavenging activity at the low concentration of
0.02 mg/mL. The IC50 estimated for C. sieberiana was















Figure 1 Reducing power of C. sieberiana roots bark extract. L-ascorbic acid (LAA) was used as a reference compound. Results are means ±
SEM of n = 3.
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As shown in Figure 4 the antioxidant activity was dose
dependent and reached a plateau (about 77-87% inhib-
ition) when the concentration of C. sieberiana exceeded
0.06 mg/mL. This result indicates that the antioxidant
activity of C sieberiana is only about 17% that of LAA as
shown by the peroxidation in the presence of 1 mM lino-
leic acid. The IC50 estimated for C. sieberiana was
0.012 ± 0.004 mg/mL and that for LAA was
0.006 ± 0.002 mg/mL.
Ferrous ion chelating effect
The ferrous ion chelating activity of the C. sieberiana roots
extract shows a linear response curve and graph analysis
shows IC50 estimation was 3.20± 0.24 mg/mL for C. sie-
beriana and 0.28± 0.024 mg/mL for LAA (Figure 5).
PGE2, PGI2 and sPLA2 studies
Daily administration of the roots extract for 28 days pro-
duced a dose dependent increase in the amounts of gastric
mucosal PGE2 and 6-keto PGF1α synthesised (Table 1).
Compared with the control, PGE2 increased by 37.7% in
the extract low dose (250 mg/kg body weight), 64.7% in
the extract medium dose (500 mg/kg body weight) and
82.4% in the extract high dose (750 mg/kg body weight).All the doses of the roots extract produced significant
increases in 6-keto PGF1α by 28.3% in the low dose, 61.7%
in the medium dose and 88.6% in the high dose.
Oral administration of the roots extract also produced a
significant inhibition of serum sPLA2 activity but no sig-
nificant change in the amount of serum sPLA2 protein.
Compared with the control, the low dose produced 21.2%
decrease, whilst the medium dose and the high dose pro-
duced 31.3% and 60.2% decrease in serum sPLA2 activity
respectively.
Phytochemical screening
Phytochemical screening revealed the presence of sapo-
nins, flavonoids, anthraquinones and tannins in the roots
extract. Thin layer chromatography revealed by their reac-
tion with FeCl3 and their fluorescence under UV-light
indicated that the roots extract contains flavonol/flavon-
oid/flavone or related compounds with polyhydroxy and/
or phenolic groups.
Acute toxicity
In F344 rats of either sex, the extracts (5–2000 mg/kg, p.
o) given as a single dose did not produce any signs of
acute toxicity. No mortality was observed during the
study period of 14 days and at necropsy, no gross































Figure 2 DPPH radical scavenging activity of C. sieberiana roots bark extract. L-ascorbic acid (LAA) was used as a reference compound.
Results are means ± SEM of n= 3.
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The present study was undertaken to investigate the
antioxidant and gastric cytoprotective prostaglandin
properties of the aqueous roots extract of C. sieberiana,
which we had previously demonstrated to possess anti-
ulcerogenic properties. Gastric ulcer disease is a multi-
factorial disease and among the various properties
implicated in its pathophysiology is the role played by
free radicals. Hence antioxidants which can scavenge free
radicals are expected to heal or prevent gastric ulcers.
Several methods developed to measure the efficiency of
antioxidants focus on different mechanisms of the oxi-
dant defence system. In most of the systems, irrespective
of the stage in the oxidative chain in which the antioxi-
dant action is measured, most non-enzymatic anti-oxida-
tive activity is mediated by redox reactions. The redox
potentials of compounds are related to their antioxidant
activity against free radicals such as peroxyl or hydroxylradicals, which have more positive redox potentials [25].
As shown in Figure 1 the reducing power increased as
the extract concentration increased indicating some
compounds in the roots extract were both electron
donors and could react with free radicals to converts
them into more stable products to terminate radical
chain reactions. This result indicates that although the
reducing power of LAA was slightly higher it was not
significantly different from that of C. sieberiana (p> 0.05).
The significant reducing powers recoded therefore sug-
gested that the roots extract of C. sieberiana would have
significant antioxidant action which was
subsequently confirmed by its scavenging action of free
radicals generated by DPPH.
In solution, DPPH generates free radicals whose odd
electrons become paired off in the presence of a hydro-
gen donor. The DPPH radical has been widely used to















































Figure 3 Hydroxyl radical scavenging activity of C. sieberiana roots bark extract. L-ascorbic acid (LAA) was used as a reference compound.
Results are means ± SEM of n= 3.
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for free radicals originating in lipids [26]. In DPPH assay
the lower the IC50, the better it is able to scavenge the
radicals, particularly peroxy radicals which are the pro-
pagators of the auto-oxidation of lipid molecules and
thereby break the free radical chain reaction. Like the
reducing power, at the IC50 of 0.075 ± 0.006 mg/mL,
the DPPH scavenging activity of the crude extract
was 63.2% that of LAA which indicates that the roots ex-
tract contains compounds that have strong antioxidant
properties. Hydroxyl radical is the principal contributor
for tissue injury. The deoxyribose method is used in de-
termining the rate constants of reactions involving hy-
droxyl radicals. The reaction involves the incubation of a
mixture of FeCl3-EDTA, H2O2 and ascorbate with de-
oxyribose in phosphate buffer (pH 7.4). The hydroxyl
radicals generated from the mixture attack the deoxyri-
bose and result in a series of reactions that cause the for-
mation of MDA. A hydroxyl radical scavenger added to
the reaction mixture will therefore compete with deoxy-
ribose for the availability of hydroxyl radicals, therebyreducing the amount of MDA formed. In this study, the
roots extract of C. sieberiana was able to achieve a 62%
maximum scavenging activity indicating that it contains
compounds that inhibit hydroxyl scavenging activity.
Lipid peroxidation has been implicated in the patho-
genesis of various diseases including gastric ulcer disease
in both humans [27] and experimental animals [28]. It is
well established that bio-enzymes are very much suscep-
tible to lipid peroxides, which is considered to be the
starting point of many degenerative processes. This re-
sult indicates that the antioxidant activity of C sieberiana
is only about 17% that of LAA as shown by the peroxida-
tion in the presence of 1 mM linoleic acid which was sig-
nificantly lower compared with LAA. The chelating
ability of the extract measures how effective the com-
pounds in it can compete with ferrozine for Fe2+. The
Fe2+-ferrozine complex has maximum absorbance at
562 nm and a large decrease in absorbance indicates
strong chelating power. By forming a stable Fe2+ chelate,
an extract with high chelating power reduces the free Fe2

































Figure 4 Antioxidant activity of C. sieberiana roots bark extract against linoleic acid peroxidation induced by haemoglobin. L-ascorbic
acid (LAA) was used as a reference compound. Results are means ± SEM of n = 3.
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results indicate that the crude roots extract can
chelate free Fe2+.
The observed antioxidant activity is significant because
free radicals have been implicated to mediate in stress,
NSAID and H. Pylori induced gastric ulcers [5,29]. Neu-
trophil adherence to the endothelium of gastric microcir-
culation has also been shown to be critical in mucosal
injury in animals and such adherence is believed to liber-
ate oxygen radicals, resulting in the release of proteases
and obstructing capillary blood flow or causing lipid per-
oxidation and damaging cell membranes [30]. Therefore
the reported anti-ulcer activity of the roots extract of C.
sieberiana could be due in part to its strong reducing
and antioxidant properties.
Phytochemical analysis detected alkaloids, saponins,
anthraquinones, tannins and flavonoids in the C. sieberi-
ana roots extract. TLC spots revealed by their reaction
with ferric chloride and their fluorescence under UV
light indicated that flavonol/flavonoid/flavone or related
compounds with polyhydroxy and/or phenolic groupsconstituted major chemical substances in the roots ex-
tract. Evidence of the presence of flavonol/flavonoid/fla-
vone or a related compound with polyhydroxy and/or
phenolic groups is consistent with the significant antioxi-
dant effect of the roots extract. Flavonoids or poly-
phenolic substances exert antioxidant actions by
scavenging free radicals, chelating metal ions or inhibit-
ing enzyme systems that generate free radicals. Several
studies demonstrated that flavonoids from various plants
are reportedly capable of preventing the occurrence of
gastric ulcer. This may take place through an increase in
the amounts of neutral glycoproteins and in prostaglan-
din concentrations, and inhibition of histamine secretion
from mast cells by inhibition of histidine decarboxylase,
thus reducing stimulation of H2 receptors, or by secre-
tion of prostaglandin-like compounds [31]. Another pos-
sible mechanism of action for inhibiting ulcer
occurrences is by decreasing pepsin secretion and activ-
ity. In addition, several studies cited by Middleton and
Kandaswami [32], indicate that certain flavonoids have





























Figure 5 Ferrous ion chelating effect of C. sieberiana roots bark extract. L-ascorbic acid (LAA) was used as a reference compound. Results
are means ± SEM of n = 3.
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suggests that flavonoids and/or polyphenols may be re-
sponsible for the reported gastric mucus protection and
anti-ulcer properties of the roots bark extract of C.
sieberiana.
The major prostaglandins produced by human and ro-
dent gastric mucosa are PGE2 and PGI2 which are vasodila-
tors in the gastrointestinal mucosa [11]. The vasodilatory
properties of these two molecules may increase mucus pro-
duction and reduce acid and pepsin levels in the stomach,
thereby make an important contribution to gastric mucosal
defence and facilitate the repair of pre-existing ulcers in the
gastrointestinal mucosa [33,34]. The present results show
that the significant dose-dependent increase in gastric mu-
cosal PGE2 and PGI2 (82.4% and 88.6% respectively in the
high dose) in the absence of induced gastric ulcers is an in-
dicator of anti-ulcerogenic activity of the roots bark extract.
These results confirm an earlier study [2] on the anti-
ulcerogenic properties of the roots bark extract which
showed that its gastric cytoprotective effect in rats was
reduced significantly by pre-treatment with indomethacin,
an NSAID prostaglandin inhibitor.The inflammatory process which occurs during gastric
ulceration is also known to be a key component of muco-
sal defence against exogenous and endogenous factors.
However, while the acute inflammatory response is aimed
at reducing mucosal injury, some of the inflammatory
mediators released increase the susceptibility of the stom-
ach to damage induced by NSAIDs or other topical irri-
tants, and thereby contributes to the generation of
mucosal injury in certain circumstances [11]. Several of
these inflammatory mediators including histamine, tumor
necrosis factor-α, platelet-activating factor, interleukin-1,
interleukin-8 and leukotriene B4 have been shown to be
down-regulated by endogenous generation of prostaglan-
dins [11]. In addition prostaglandins are also potent inhi-
bitors of leukocyte adherence to the vascular
endothelium which is a hallmark of inflammation such
that leukocyte adherence that occurs within the gastro-
intestinal microcirculation following administration of an
NSAID can be prevented by prostaglandin administration
[35,36]. It is imperative to note that activated inflamma-
tory cells may also be potential sources of free radicals
[37] which further aggravate the damaged gastric mucosa.
Table 1 Effect of roots bark extract of C. sieberiana on
mucosal PGE2 and 6-keto PGF1α levels and serum sPLA2













Control vehicle 0.17 ± 0.02 2.10 ± 0.19 26.44 ± 0.69
Extract 250 0.23 ± 0.01* 2.69 ± 0.08* 20.84 ± 0.65{
“ 500 0.28 ± 0.02† 3.39 ± 0.34* 18.16 ± 0.68{
“ 750 0.31 ± 0.02{ 3.95 ± 0.19{ 10.52 ± 0.52{
* p< 0.05, statistically significant relative to control.
† p< 0.01, statistically significant relative to control.
{ p< 0.001, statistically significant relative to control.
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dants as anti-ulcerogenic agents.
The roots extract did not show decline of sPLA2 protein;
however, enzymatic activity of sPLA2 in serum was defin-
itely inhibited. Thus, the impact may be on the enzyme-
substrate level possibly by blunting sPLA2 interaction with
its substrates rather than on the synthesis of sPLA2. It was
expected that the stimulation of endogenous generation of
gastric mucosal PGE2 and PGI2 will be coupled with an in-
crease of arachidonic acid signaling as a result of stimulated
sPLA2. The stimulation of endogenous generation of gastric
mucosal PGE2 and PGI2 despite the inhibition of serum
sPLA2 is interesting. An important clue may lie in the fact
that the study measured sPLA2 in the serum and not in the
stomach homogenate hence it is possible the extract is
exerting its effect selectively at the two different locations
due to the various isoforms of sPLA2 discovered [38,39].
However, the inhibition of sPLA2 in the serum confirms an
earlier report which suggests that the inhibition of serum
sPLA2 by C. sieberiana roots bark extract may be partly re-
sponsible for its therapeutic use as an anti-asthmatic and
anti-inflammatory agent [40]. We are currently conducting
studies into the effect of different fractionated portions of
the extract on sPLA2 activity and expression in different tis-
sues in a bid to elucidate its mechanism of action.
Despite these findings, inhibition of gastric mucosal
sPLA2 activity may indicate anti-ulcerogenic abilities. Is-
chemic insult to intestinal mucosa causes excessive pro-
duction of oxygen derived free radicals (ODFR) that may
initiate a chain of reactions in membrane-bound lipids
leading to lipid peroxidation and PLA2 activation [41,42].
Inhibition of this cascade by scavenging ODFR and/or
inhibiting sPLA2 could therefore be an effective tool to
protect gastrointestinal mucosa against chemically
induced lesions.
Conclusions
Antioxidant properties can be primary or secondary. Pri-
mary antioxidants scavenge radicals to inhibit chain initi-
ation and break chain propagation. Secondary antioxidantssuppress the formation of radicals and protect against oxi-
dative damage by binding to metal ions strongly. Primary
antioxidant properties are generally measured by DPPH
assay and ferric reducing antioxidant power whilst second-
ary antioxidant properties is generally measured by the fer-
rous ion chelating activity which measures the chelating
ability of the extract. In this study we demonstrated that
roots bark extract of C. sieberiana have both DPPH scav-
enging activity and ferric reducing power and can scavenge
hydroxyl radicals. The extract was also able to arrest lipid
peroxidation and chelate ferrous ion. The roots extract
therefore do possess both primary and secondary antioxi-
dant properties which may be due to the high content of
phenolic compounds. The roots extract was responsible
for the observed stimulation of endogenous generation of
gastric mucosal PGE2 and PGI2, and the inhibition of
sPLA2 activity in serum. These findings suggest that the
plant extract contains bimolecules which has high antioxi-
dant properties and can stimulate the endogenous gener-
ation of gastric mucosal PGE2 and PGI2 which may be
responsible for the therapeutic use as an anti-ulcer agent.
The extract also showed no sign of acute toxicity at a dose
of 2000 mg/kg body weight p.o. At present, it remains un-
certain how the plant extract can inhibit serum sPLA2 but
stimulate endogenous generation of gastric mucosal PGE2
and PGI2 and further studies are currently underway to
clarify this by investigating the effect of different fractions
of the extract on sPLA2 activity and expression in different
tissues.
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